
无数据
无数据
无数据
| CAS Number | 79-57-2 |
| Catalog Number | AG019FSH(AGN-PC-0UEQJM) |
| Chemical Name | Oxytetracycline |
| IUPAC Name | (4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide |
| InChI | InChI=1S/C22H24N2O9/c1-21(32)7-5-4-6-8(25)9(7)15(26)10-12(21)17(28)13-14(24(2)3)16(27)11(20(23)31)19(30)22(13,33)18(10)29/h4-6,12-14,17,25-26,28,30,32-33H,1-3H3,(H2,23,31)/t12-,13-,14+,17+,21-,22+/m1/s1 |
| InChI Key | OWFJMIVZYSDULZ-PXOLEDIWSA-N |
| MDL Number | MFCD00003700 |
| Molecular Formula | C22H24N2O9 |
| Molecular Weight | 460.4340 |
| SMILES | O=C(C(C4=O)=C(O)[C@@H](N(C)C)[C@]3([H])[C@@H](O)[C@]2([H])[C@](C)(O)C1=C(C(C2=C(O)[C@]34O)=O)C(O)=CC=C1)N |
| UNII | SLF0D9077S |
| Synonyms | Bisolvomycin,
Geomycin,
Hydroxytetracycline,
Oxyterracin,
Oxyterracine,
Oxytetracid,
Oxytetracycline,
Oxytetracycline Anhydrous,
Oxytetracycline Calcium,
Oxytetracycline Dihydrate,
Oxytetracycline Hydrochloride,
Oxytetracycline Monohydrochloride,
Oxytetracycline Sulfate (2:1),
Oxytetracycline, (4a beta,5 beta,5a beta,12a beta)-Isomer,
Oxytetracycline, (5 beta)-Isomer,
Oxytetracycline, Anhydrous,
Oxytetracycline, Calcium (1:1) Salt,
Oxytetracycline, Disodium Salt, Dihydrate,
Oxytetracycline, Sodium Salt,
Terramycin,
oxytetracycline,
Terramycin,
79-57-2,
Oxytetracyclin,
Oxitetraciclina,
Oxymycin,
Oxyterracine,
Terrafungine,
Oxytetracyclinum,
Oxitetracyclin,
Adamycin,
Biostat,
Geomycin,
Ryomycin,
Oxitetracyclinum,
Oxyterracin,
Oxyterracyne,
Solkaciclina,
Dabicycline,
Fanterrin,
Geotilin,
Imperacin,
Lenocycline,
Oksisyklin,
Proteroxyna,
Riomitsin,
Terramitsin,
Ursocyclin,
Ursocycline,
Macocyn,
Oxypam,
Tarocyn,
Tarosin,
Teravit,
Tetran,
Antibiotic TM 25,
Liquamycin LA 200,
Oxytetracycline (anhydrous),
Biostat PA,
Oxytetracycline (Terramycin),
Oxytetracycline anhydrous,
Oxytetracycline amphoteric,
Oxysteclin,
Oxymykoin,
Stevacin,
Vendarcin,
Oxytetracid,
5-Hydroxytetracycline,
Ossitetraciclina,
Pennox 200,
Oxy-Kesso-tetra,
Terramycin im,
Oxytetracycline [INN],
Berkmycen,
Mycoshield TMQTHC 20,
Terramycin Q50,
OTC (antibiotic),
Dalimycin,
Oxacycline,
Unimycin,
Oxytetracycline calcium,
Medamycin,
Ossitetraciclina [DCIT],
Tetracycline, 5-hydroxy-,
UNII-SLF0D9077S,
Oxytetracyclinum [INN-Latin],
Mepatar,
Stecsolin,
Oxydon,
Oxitetraciclina [INN-Spanish],
Geomycin (Streptomyces vimosus),
HSDB 3145,
NCI-C56473,
Oxytetracycline base,
EINECS 201-212-8,
LA 200,
Oxytetracycline(Terramycin),
BRN 2714587,
C22H24N2O9,
MLS000069429,
SLF0D9077S,
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide,
CHEBI:27701,
Oxytetracycline (internal use),
TM 5,
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-,
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6S,12aS)-,
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha))-,
2058-46-0,
SMR000059000,
NSC-9169,
OGYE Selective Supplement; Oxytetracycline,
Terramicina Oftalmica,
79-57-2 (ANHYDROUS),
OTC,
Oxytetracycline, 'can be used as secondary standard',
Geomycin (Streptomyces rimosus),
Embryostat,
Galsenomycin,
Oxitetracycline,
SR-01000003006,
Hydroxytetracyclinum,
Oxytetracycline,(S),
AC1NQXTY,
AC1NQZMP,
5-Hydroxy-Tetracycline,
Spectrum_001055,
Opera_ID_661,
AC1L1MWD,
Prestwick0_000307,
Prestwick1_000307,
Prestwick2_000307,
Prestwick3_000307,
Spectrum2_000988,
Spectrum3_000536,
Spectrum4_000466,
Spectrum5_001148,
SCHEMBL2899,
CHEMBL1517,
DSSTox_CID_14260,
DSSTox_RID_79133,
DSSTox_GSID_34260,
BSPBio_000274,
BSPBio_002151,
KBioGR_000912,
KBioSS_001535,
4-14-00-02633 (Beilstein Handbook Reference),
DivK1c_000225,
SCHEMBL560497,
SPBio_001055,
SPBio_002493,
BPBio1_000302,
CHEMBL461529,
CHEMBL1401333,
DTXSID1034260,
NSC9169 (HCL),
SCHEMBL13169109,
SCHEMBL13782651,
CTK6H8882,
KBio1_000225,
KBio2_001535,
KBio2_004103,
KBio2_006671,
KBio3_001651,
6153-64-6 (di-hydrate),
BIB6305,
IWVCMVBTMGNXQD-PXOLEDIWSA-N,
NINDS_000225,
OWFJMIVZYSDULZ-PXOLEDIWSA-N,
BDBM241973,
HY-B0275,
2058-46-0 (mono-hydrochloride),
Tox21_302380,
LMPK07000005,
MFCD00003700,
s1773,
ZINC95626782,
AKOS015951277,
AKOS015961254,
ZINC100026355,
ZINC100303028,
API0003726,
CS-2265,
DB00595,
EBD2197445,
MCULE-5398230579,
CAS-79-57-2,
IDI1_000225,
NCGC00091268-04,
NCGC00091268-05,
NCGC00091268-06,
NCGC00091268-07,
NCGC00091268-08,
NCGC00091268-09,
NCGC00091268-11,
NCGC00091268-12,
NCGC00188956-01,
NCGC00255168-01,
AC-12777,
AC-13466,
AN-23998,
BC202856,
E703,
LS-93860,
S470,
7179-50-2 (calcium (1:1) salt),
SBI-0051473.P003,
AB1009358,
AB1009512,
FT-0603288,
ST50307307,
SW196796-3,
3,5,6,10,12,12a-hexahydroxy-6-methyl-,
C06624,
Oxytetra Selective Supplement, for microbiology,
AB00053514_04,
AB00053514_05,
AB01274728-01,
AB01274728_02,
135740-EP2275422A1,
135740-EP2292608A1,
6153-65-7 (di-hydrochloride salt, di-hydrate),
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-,
SR-01000003006-5,
1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene,
Oxytetracycline, British Pharmacopoeia (BP) Reference Standard,
Oxytetracycline, European Pharmacopoeia (EP) Reference Standard,
(2Z,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione,
(2Z,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione,
(4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione,
(4s,4ar,5s,5ar,6s,12as)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4a,5a,6,12a-tetrahydrotetracene-1,3,12(2h,4h,5h)-trione,
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,11,12a-hexahydroxy-6-methyl-1,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide,
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide,
(4S,5S,6S,12aS,4aR,5aR)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl -1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide,
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4S-(4-alpha,4a-alpha,5-alpha,5a-alpha,6-beta,12a-alpha))-,
Liquamycin,
Bisolvomycin,
Tetrachel,
Abbocin,
Oxytetracycline HCl,
Hydroxytetracycline,
glomycin,
Biosolvomycin,
Oxybiocycline,
Aquacycline,
Clinimycin,
Dalinmycin,
Hydrocyclin,
Oxycycline,
Alamycin,
Chrysocin,
Engemycin,
Intaloxin,
Liquachel,
Oxamycen,
Oxytetral,
Oxytetrin,
Oxytracyl,
Terraject,
Elinton,
Macodyn,
Otetryn,
Oxatets,
Oxlopar,
Oxyject,
Toxinal,
Biotet,
Oxatet,
Oxytet,
oxytetracyclin-,
Oxyvet,
Oxy-Dumocyclin,
Tetra-Tablinen,
Oxy-Terachel,
Bi Steclin,
-2-carboxamide,
Oxytetracycline dihydrate,
Ia-Loxin,
Oxy-Rivo,
Uri-Tet,
Oxytetracycline.HCl,
Tetran hydrochloride,
Urobiotic-250,
Liquamycin injectable,
Oxy WS,
Oxyject 100,
Caswell No. 628,
Oxy-Tet 50,
Terramycin hydrochloride,
Tetracycline, 5-oxy-,
OXYTETRACYCLINE HYDROCHLORIDE,
OXY-WS,
Oxytetracycline, Anhydrous,
Oxy-DE 250,
Hydroxytetrazyklinhydrochlorid,
Oxytetracycline, Sodium Salt,
UNII-4U7K4N52ZM,
Oxytetracyclini hydrochloridum,
CCRIS 200,
C22H24N2O9.ClH,
UNII-X20I9EN955,
Neo-oxy 100/100 MR,
TM 5 (VAN),
Oxytetracycline Monohydrochloride,
Oxytetracycline Sulfate (2:1),
NSC 9169,
CID6604,
NSC9169,
5-Hydroxytetracycline hydrochloride,
Oxytetracycline - 100MG 100mg,
Oxytetracycline, (5 beta)-Isomer,
Oxytetracycline hydrochloride [JAN],
C22-H24-N2-O9.Cl-H,
EINECS 218-161-2,
5-Hydroxytetracycline monohydrochloride,
C22-H24-N2-O9,
Oxytetracycline, Calcium (1:1) Salt,
CID5280972,
CID5282186,
CS-O-14814,
EPA Pesticide Chemical Code 006308,
component of Terramycin Topical Ointment,
Oxytetracycline hydrochloride [USP:JAN],
Oxytetracycline, disodium salt, dihydrate,
Oxytetracycline hydrochloride [USAN:JAN],
AI3-50164,
Oxytetracycline hydrochloride (internal use),
B2000,
6153-64-6,
D010118,
Oxytetracycline, (4a beta,5 beta,5a beta,12a beta)-Isomer,
(2E,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione,
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide,
15251-48-6,
2-naftacenocarboxamida, 4-(dimetilamino)-1,4,4 a, 5,5 a, 6,11,12 a-octahidro-3, 5,6,10,12,12 a-hexahidroxi-6-metil-1, 11-dioxo-, (4s, 4ar, 5s, 5ar, 6s, 12as)-,
2-Naftacenocarboxamida, 4-(dimetilamino)-1,4,4 a, 5,5 a, 6,11,12 a-octahidro-3, 5,6,10,12,12 a-hexahidroxi-6-metil-1, 11-dioxo-, clorhidrato (1:1), (4S, 4aR, 5S, 5aR, 6S, 12aS)-,
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, [4S-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.,6.beta.,12a.alpha.)]-,
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, [4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha)]-,
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, dihydrate, (4S,4aR,5S,5aR,6S,12aS)-,
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride,
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S,4aR,5S,5aR,6S,12aS)-,
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha))-,
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.,6.beta.,12a.alpha.)]-,
4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride,
|
| Complexity | 1000 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 6 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 460.148g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 33 |
| Hydrogen Bond Acceptor Count | 10 |
| Hydrogen Bond Donor Count | 7 |
| Isotope Atom Count | 0 |
| Molecular Weight | 460.439g/mol |
| Monoisotopic Mass | 460.148g/mol |
| Rotatable Bond Count | 2 |
| Topological Polar Surface Area | 202A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -1.6 |
| Symbol: | |
| Hazard statements | |
| Precautionary statements | |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

